Stevanato Group S.p.A. (STVN) Stock Forecast, Price Target & Predictions
STVN Stock Forecast
Stevanato Group S.p.A. stock forecast is as follows: an average price target of $25.50 (represents a 22.89% upside from STVN’s last price of $20.75) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
STVN Price Target
The average price target for Stevanato Group S.p.A. (STVN) is $25.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $33.00 to $19.00. This represents a potential 22.89% upside from STVN's last price of $20.75.
STVN Analyst Ratings
According to 3 Wall Street analysts, Stevanato Group S.p.A.'s rating consensus is 'Buy'. The analyst rating breakdown for STVN stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Stevanato Group S.p.A. Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 07, 2024 | Patrick Donnelly | Citigroup | $28.00 | $19.87 | 40.92% | 34.94% |
| Jul 15, 2024 | Drew Ranieri | Morgan Stanley | $22.00 | $21.71 | 1.34% | 6.02% |
| Sep 26, 2023 | Jacob Johnson | Stephens | $33.00 | $27.07 | 21.91% | 59.04% |
| Jan 06, 2023 | - | Morgan Stanley | $22.00 | $19.84 | 10.86% | 6.02% |
| Apr 25, 2022 | - | Wells Fargo | $19.00 | $16.59 | 14.53% | -8.43% |
The latest Stevanato Group S.p.A. stock forecast, released on Aug 07, 2024 by Patrick Donnelly from Citigroup, set a price target of $28.00, which represents a 40.92% increase from the stock price at the time of the forecast ($19.87), and a 34.94% increase from STVN last price ($20.75).
Stevanato Group S.p.A. Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $25.00 |
| Last Closing Price | $20.75 | $20.75 | $20.75 |
| Upside/Downside | -100.00% | -100.00% | 20.48% |
In the current month, the average price target of Stevanato Group S.p.A. stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Stevanato Group S.p.A.'s last price of $20.75. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 07, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Sep 26, 2023 | Stephens | - | Overweight | Initialise |
| Jul 31, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
| Jan 06, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Stevanato Group S.p.A.'s last stock rating was published by Citigroup on Aug 07, 2024. The company gave STVN a "Buy" rating, the same as its previous rate.
Stevanato Group S.p.A. Financial Forecast
Stevanato Group S.p.A. Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $237.99M | $292.10M | $245.26M | $234.25M | $212.07M | $232.57M | $214.53M | $203.96M |
| Avg Forecast | $422.05M | $373.70M | $351.13M | $315.55M | $374.20M | $322.88M | $299.18M | $270.56M | $347.57M | $305.48M | $273.05M | $255.91M | $360.76M | $296.37M | $273.31M | $253.70M | $290.99M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| High Forecast | $427.91M | $378.88M | $356.00M | $319.93M | $379.40M | $327.36M | $303.34M | $272.15M | $352.58M | $309.72M | $276.84M | $259.47M | $365.36M | $300.48M | $277.10M | $257.22M | $295.03M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| Low Forecast | $415.69M | $368.07M | $345.84M | $310.80M | $368.57M | $318.02M | $294.68M | $268.96M | $339.55M | $300.88M | $268.94M | $252.06M | $352.88M | $291.91M | $269.19M | $249.88M | $286.61M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.00% | 1.02% | 0.98% | 0.90% | 0.93% | 0.90% | 0.85% |
Stevanato Group S.p.A.'s average Quarter revenue forecast for Jun 23 based on 3 analysts is $273.31M, with a low forecast of $269.19M, and a high forecast of $277.10M. STVN's average Quarter revenue forecast represents a 14.84% increase compared to the company's last Quarter revenue of $237.99M (Mar 23).
Stevanato Group S.p.A. EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $59.21M | $70.90M | $64.42M | $59.88M | $53.31M | $59.86M | $41.76M | $61.55M |
| Avg Forecast | $95.20M | $84.29M | $79.20M | $71.18M | $84.41M | $72.83M | $67.48M | $61.03M | $78.40M | $68.91M | $61.59M | $57.73M | $81.37M | $66.85M | $61.65M | $57.23M | $65.64M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $39.79M |
| High Forecast | $96.52M | $85.46M | $80.30M | $72.16M | $85.58M | $73.84M | $68.42M | $61.39M | $79.53M | $69.86M | $62.45M | $58.53M | $82.41M | $67.78M | $62.50M | $58.02M | $66.55M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $47.75M |
| Low Forecast | $93.77M | $83.02M | $78.01M | $70.11M | $83.14M | $71.73M | $66.47M | $60.67M | $76.59M | $67.87M | $60.66M | $56.86M | $79.60M | $65.84M | $60.72M | $56.36M | $64.65M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $31.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.08% | 1.19% | 1.11% | 1.01% | 1.06% | 0.78% | 1.55% |
3 analysts predict STVN's average Quarter EBITDA for Jun 23 to be $61.65M, with a high of $62.50M and a low of $60.72M. This is 4.12% upper than Stevanato Group S.p.A.'s previous annual EBITDA (Mar 23) of $59.21M.
Stevanato Group S.p.A. Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.27M | $48.30M | $36.22M | $30.53M | $27.72M | $44.60M | $18.66M | $34.44M |
| Avg Forecast | $70.04M | $58.70M | $48.83M | $41.30M | $54.62M | $43.58M | $34.16M | $28.75M | $54.37M | $38.50M | $28.66M | $32.51M | $57.62M | $43.84M | $38.76M | $35.53M | $46.37M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $21.92M |
| High Forecast | $71.30M | $59.76M | $49.71M | $42.05M | $55.61M | $44.37M | $34.78M | $29.27M | $57.09M | $39.19M | $29.35M | $33.75M | $58.66M | $44.78M | $39.45M | $36.17M | $47.20M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $26.30M |
| Low Forecast | $68.67M | $57.55M | $47.88M | $40.50M | $53.56M | $42.73M | $33.50M | $28.19M | $51.65M | $37.75M | $27.98M | $31.26M | $54.88M | $42.90M | $38.00M | $34.84M | $45.46M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $17.53M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 1.04% | 1.02% | 0.92% | 0.91% | 1.41% | 0.62% | 1.57% |
Stevanato Group S.p.A.'s average Quarter net income forecast for Jun 23 is $38.76M, with a range of $38.00M to $39.45M. STVN's average Quarter net income forecast represents a 37.11% increase compared to the company's last Quarter net income of $28.27M (Mar 23).
Stevanato Group S.p.A. SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.27M | $33.20M | $25.82M | $29.35M | $23.42M | $22.25M | $29.37M | $11.45M |
| Avg Forecast | $48.17M | $42.65M | $40.08M | $36.02M | $42.71M | $36.85M | $34.15M | $30.88M | $39.67M | $34.87M | $31.17M | $29.21M | $41.18M | $33.83M | $31.20M | $28.96M | $33.21M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $7.29M |
| High Forecast | $48.84M | $43.25M | $40.63M | $36.52M | $43.30M | $37.37M | $34.62M | $31.06M | $40.24M | $35.35M | $31.60M | $29.62M | $41.70M | $34.30M | $31.63M | $29.36M | $33.67M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $8.75M |
| Low Forecast | $47.45M | $42.01M | $39.47M | $35.47M | $42.07M | $36.30M | $33.63M | $30.70M | $38.76M | $34.34M | $30.70M | $28.77M | $40.28M | $33.32M | $30.73M | $28.52M | $32.71M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $5.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 1.00% | 0.94% | 1.07% | 0.87% | 0.78% | 1.08% | 1.57% |
Stevanato Group S.p.A.'s average Quarter SG&A projection for Jun 23 is $31.20M, based on 3 Wall Street analysts, with a range of $30.73M to $31.63M. The forecast indicates a 10.33% rise compared to STVN last annual SG&A of $28.27M (Mar 23).
Stevanato Group S.p.A. EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.11 | $0.18 | $0.14 | $0.12 | $0.10 | $0.17 | $0.07 | $0.11 |
| Avg Forecast | $0.26 | $0.22 | $0.18 | $0.15 | $0.20 | $0.16 | $0.13 | $0.11 | $0.20 | $0.14 | $0.11 | $0.12 | $0.21 | $0.16 | $0.14 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| High Forecast | $0.26 | $0.22 | $0.18 | $0.15 | $0.20 | $0.16 | $0.13 | $0.11 | $0.21 | $0.14 | $0.11 | $0.12 | $0.22 | $0.16 | $0.14 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| Low Forecast | $0.25 | $0.21 | $0.18 | $0.15 | $0.20 | $0.16 | $0.12 | $0.10 | $0.19 | $0.14 | $0.10 | $0.11 | $0.20 | $0.16 | $0.14 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.84% | 1.06% | 1.08% | 0.98% | 0.90% | 1.47% | 0.64% | 0.74% |
According to 3 Wall Street analysts, Stevanato Group S.p.A.'s projected average Quarter EPS for Jun 23 is $0.14, with a low estimate of $0.14 and a high estimate of $0.14. This represents a 29.15% increase compared to STVN previous annual EPS of $0.11 (Mar 23).
Stevanato Group S.p.A. Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $102.00 | $298.00 | 192.16% | Buy |
| AKYA | Akoya Biosciences | $3.19 | $7.90 | 147.65% | Buy |
| XRAY | DENTSPLY SIRONA | $17.77 | $40.00 | 125.10% | Hold |
| ANGO | AngioDynamics | $7.14 | $15.00 | 110.08% | Buy |
| TFX | Teleflex | $195.58 | $304.36 | 55.62% | Buy |
| ATRC | AtriCure | $36.63 | $49.57 | 35.33% | Buy |
| STVN | Stevanato Group S.p.A. | $20.75 | $25.50 | 22.89% | Buy |
| HAE | Haemonetics | $93.38 | $108.25 | 15.92% | Buy |
| NVST | Envista | $20.52 | $23.11 | 12.62% | Hold |
| ALC | Alcon | $86.89 | $93.89 | 8.06% | Buy |
| WST | West Pharmaceutical Services | $327.68 | $345.33 | 5.39% | Buy |
| MMSI | Merit Medical Systems | $104.24 | $100.78 | -3.32% | Buy |
| ICUI | ICU Medical | $178.01 | $172.00 | -3.38% | Buy |
| RMD | ResMed | $247.21 | $219.13 | -11.36% | Hold |
| ATR | AptarGroup | $175.70 | $138.00 | -21.46% | Buy |